Back
New Concept Energy Vs. Blueprint Medicines Industry Stock Comparison
Sell
20
GBR
New Concept Energy
Last Price:
$0.98
Seasonality Move:
-12.7%
Sell
46
BPMC
Blueprint Medicines
Last Price:
$129.36
Seasonality Move:
2.16%
Sell
20
New Concept Energy (GBR)
is a Sell
Is New Concept Energy a Buy, Sell or Hold?
-
The current New Concept Energy [GBR] share price is $0.98. The Score for GBR is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
GBR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
46
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $129.35. The Score for BPMC is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GBR Stock Price Chart
What is New Concept Energy's stock price today?
-
The New Concept Energy share price today is $0.98Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GBR is experiencing selling pressure, which indicates risk of future bearish movement.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $129.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight selling pressure.
GBR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.27 | Buy |
Relative Strength Index (14 RSI): | 42.77 | Sell |
Chaikin Money Flow: | -31420 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.96 - 1.32) | Sell |
Bollinger Bands (100): | (0.76 - 1.12) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.14 | Buy |
Relative Strength Index (14 RSI): | 76.77 | Buy |
Chaikin Money Flow: | -580151 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (127.95 - 128.83) | Buy |
Bollinger Bands (100): | (84.99 - 120.37) | Buy |
GBR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.06 | Sell |
20-day SMA: | 1.17 | Sell |
50-day SMA: | 1.02 | Sell |
200-day SMA: | 1.07 | Sell |
8-day EMA: | 0.79 | Buy |
20-day EMA: | 0.46 | Buy |
50-day EMA: | 0.22 | Buy |
200-day EMA: | 0.06 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 128.88 | Buy |
20-day SMA: | 128.49 | Buy |
50-day SMA: | 117.12 | Buy |
200-day SMA: | 99.05 | Buy |
8-day EMA: | 128.97 | Buy |
20-day EMA: | 127.15 | Buy |
50-day EMA: | 118.47 | Buy |
200-day EMA: | 102.67 | Buy |
New Concept Energy Earnings Growth & GBR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.
New Concept Energy Technical Analysis
Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |